Mapping molecular motions -- the "magic " of chemistry revealed. Despite the enormous number of possible arrangements of atoms during a structural transition, such as occurs with changes in charge distribution...
Click here for more information.
TORONTO, ON – Call it the ultimate nature documentary. Scientists at the University of Toronto have recorded atomic motions in real time, offering a glimpse into the very essence of chemistry and biology at the atomic level.
Their recording is a direct observation of a transition state in which atoms undergo chemical transformation into new structures with new properties – in this case the transfer of charge leading to metallic behaviour in organic molecules. It is described in a study reported in the April 18 issue of Nature.
"It's the first look at how chemistry and biology involve just a few key motions for even the most complex systems," says U of T chemistry and physics professor R. J. Dwayne Miller, principal investigator of the study. "There is an enormous reduction in complexity at the defining point, the transition state region, which makes chemical processes transferrable from one type of molecule to another. This is how new drugs or materials are made."
Miller, who holds a joint appointment as director of the Max Planck Research Group for Structural Dynamics at the Centre for Free Electron Laser Science, conducted the research with colleagues from institutions in Germany and Japan. He says nature uses this reduction principle at transition states to breathe life into otherwise inanimate matter.
"Imagine the complexity of all the enormous number of possible arrangements of atoms in DNA or any other biologically active molecule. It always does the same thing to drive a biological function. We can now see how all these possible motions become coerced along a particular pathway by a dominant player."
To help illuminate what's going on here, Miller explains that with two atoms there is only one possible coordinate or dimension for following the chemical pathway. With three atoms, two dimensions are now needed. However, with a complex molecule, it would be expected that hundreds or even thousands of dimensions would be required to map all possible trajectories of the atoms.
"In this case, chemistry would be a completely new problem for every molecule," says Miller. "But somehow there is an enormous reduction in dimensions to just a few motions, and we are now able to see exactly how this works at the atomic level of detail."
The result builds on a milestone Miller and some former graduate students first reached a decade ago.
"One of the longstanding dream experiments is to directly observe atomic motions during the defining moments that lead to structure change, and we were able to watch simple phase transitions at the atomic level back in 2003," says Miller. "This led to a new understanding that now allows for minimally invasive laser surgery. It's a testimony to the importance of basic science and never knowing where new understandings will lead."
"The first atomic movies were very grainy, much like the first motion pictures," says Miller. "The new movies are so clear one could dare say they are becoming beautiful to behold, especially when you remember you are looking at atoms moving on the fly. We've captured them at an incredibly fast rate of less than 1 millionth of a millionth of a second per frame."
The breakthrough was based on the development of ultra-bright electron sources that dates back to the 2003 work.
"Other researchers use x-rays to capture atomic motions, so no one thought we could ever develop a bright enough source based on electrons as they undergo electron-electron repulsion and would blow up without being able to capture an image on the incredibly short time scale required," says Miller. "We found a way to coerce the electrons into an ultra-short pulse sufficiently bright to literally light up atomic motions as they occur."
"Electrons interact with atoms 1 million times stronger than x-rays and can be produced with a table-top instrument to efficiently produce enormous, effective brightness for viewing atomic motions."
Funding for this research was provided by the Natural Sciences and Engineering Research Council of Canada and the Canada Foundation for Innovation. Additional support was provided by the Max Planck Society in Germany, a Grant-in-Aid for Scientific Research on Innovative Areas and the G-COE program for the field of Chemistry from The Ministry of Education, Culture, Sports, Science and Technology in Japan, and by Creative Scientific Research from The Japan Society for the Promotion of Science.
Note to media: Contact Sean Bettam at firstname.lastname@example.org to to view an animation of the research described here.
R.J. Dwayne Miller
Department of Chemistry
University of Toronto
Faculty of Arts & Science
University of Toronto
April 17, 2013 — (BRONX, NY) — Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered how the protein that blocks HIV-1 from multiplying in white blood cells is regulated. HIV-1 is the virus that causes AIDS, and the discovery could lead to novel approaches for addressing HIV-1 "in hiding" – namely eliminating reservoirs of HIV-1 that persist in patients undergoing antiretroviral therapy. The study was published today in the online edition of the journal Cell Host & Microbe.
Antiretroviral therapy can reduce blood levels of HIV-1 until ...
Federally funded safety-net clinics for the uninsured lag behind other health care providers in controlling blood pressure among the low-income patients who rely on them for care, a new Michigan State University analysis suggests.
High blood pressure, or hypertension, is a major risk factor for cardiovascular complications including heart disease and stroke, and is especially common and dangerous for patients with diabetes, said lead researcher Adesuwa Olomu, associate professor in the MSU Department of Medicine.
In recent decades, a growing share of the 67 million ...
SEATTLE, WA, and QUEBEC CITY, QC, April 17, 2013 – IDRI (Infectious Disease Research Institute), a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc. (TSX: MDG; OTCQX: MDCGF), a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today reported positive interim results from a Phase I clinical trial for an H5N1 Avian Influenza VLP vaccine candidate ("H5N1 ...
AUGUSTA, Ga. – Pain is an undeniable focal point for patients with sickle cell disease but it's not the best focus for drug development, says one of the dying breed of physicians specializing in the condition.
Rather scientists need to get back to the crux of the disease affecting 1 in 500 black Americans and find better ways to prevent the hallmark sickling that impedes red blood cells' oxygen delivery, damaging blood vessel walls and organs along the way, said Dr. Abdullah Kutlar, Director of the Sickle Cell Center at the Medical College of Georgia at Georgia Regents ...
Smaller begets bigger.
Such is often the case for galaxies, at least: the first galaxies were small, then eventually merged together to form the behemoths we see in the present universe.
Those smaller galaxies produced stars at a modest rate; only later—when the universe was a couple of billion years old—did the vast majority of larger galaxies begin to form and accumulate enough gas and dust to become prolific star factories. Indeed, astronomers have observed that these star factories—called starburst galaxies—became prevalent a couple of billion years after the Big ...
MINNEAPOLIS – Americans with brain diseases such as Alzheimer's disease, Parkinson's disease or multiple sclerosis (MS) who need to see a neurologist may face longer wait times or have more difficulty finding a neurologist, according to a new study published in the April 17, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology. The findings are being released as nearly 150 neurologists will descend on Capitol Hill next Tuesday, April 23, 2013, to encourage Congress to protect patients' access to neurologists and ensure there will be ...
Teenagers are risk-takers — they're more likely than children or adults to experiment with illicit substances, have unprotected sex, and drive recklessly. But research shows that teenagers have the knowledge and ability to make competent decisions about risk, just like adults. So what explains their risky behavior?
In a new report, psychological scientists Laurence Steinberg and Jason Chein of Temple University and Dustin Albert of Duke University argue that some teens' risky behavior reflects the unique effect of peer influence on the still-developing teenage brain.
CAMBRIDGE, MA -- Osteoarthritis, which affects at least 20 percent of adults in the United States, leads to deterioration of cartilage, the rubbery tissue that prevents bones from rubbing together. By studying the molecular properties of cartilage, MIT engineers have now discovered how the earliest stages of arthritis make the tissue more susceptible to damage from physical activities such as running or jumping.
The findings could help researchers develop tests to diagnose arthritis earlier in patients at high risk for the disease and also guide engineers in designing ...
This year, astronomers around the world have been celebrating the 50th anniversary of X-ray astronomy. Few objects better illustrate the progress of the field in the past half-century than the supernova remnant known as SN 1006.
When the object we now call SN 1006 first appeared on May 1, 1006 A.D., it was far brighter than Venus and visible during the daytime for weeks. Astronomers in China, Japan, Europe, and the Arab world all documented this spectacular sight. With the advent of the Space Age in the 1960s, scientists were able to launch instruments and detectors ...
Neuroscientists at The University of Texas Health Science Center at Houston (UTHealth) have taken a major step in their efforts to help people with memory loss tied to brain disorders such as Alzheimer's disease.
Using sea snail nerve cells, the scientists reversed memory loss by determining when the cells were primed for learning. The scientists were able to help the cells compensate for memory loss by retraining them through the use of optimized training schedules. Findings of this proof-of-principle study appear in the April 17 issue of the Journal of Neuroscience.